Item

Androgen suppression, PSA response, toxicity and longer-term outcomes with transdermal oestradiol (tE2) patches compared with LHRH analogues for the treatment of locally advanced prostate cancer, the phase III PATCH (NCT00303784) and STAMPEDE (NCT00268476) trials

Gilbert, D. C.
; 
Nankivell, M.
; 
Sehjal, J.
; 
Rush, H.
; 
Mangar, S.
; 
Gale, J.
; 
Alhasso, A.
; 
Kockelbergh, R.
; 
Deighan, J.
; 
Griffiths, A.
... show 8 more
Citations
Altmetric:
Abstract
Authors
Gilbert, D. C.
Nankivell, M.
Sehjal, J.
Rush, H.
Mangar, S.
Gale, J.
Alhasso, A.
Kockelbergh, R.
Deighan, J.
Griffiths, A.
Carvalho, C.
Brierly, R.
Madaan, S.
Cross, W.
Clarke, N.
James, N.
Parmar, M.
Langley, R. E.
Affiliation
UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Clin Oncol, London, England Queen Alexandra Hosp, Dept Clin Oncol, Portsmouth, England Beatson West Scotland Canc Ctr, Dept Urol, Glasgow, Scotland Univ Hosp Leicester NHS Trust, Dept Urol, Leicester, England Ipswich Hosp, Dept Urol, Ipswich, England Darent Valley Hosp, Dept Urol, Darenth Wood Rd, Dartford, England St James Univ Hosp, Dept Urol, Leeds, England Christie & Salford Royal Hosp, Dept Urol, Manchester, England Inst Canc Res, Dept Clin Oncol, Sutton, England
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Gilbert DC, Nankivell M, Sehjal J, Rush H, Mangar S, Gale J, et al. Androgen suppression, PSA response, toxicity and longer-term outcomes with transdermal oestradiol (tE2) patches compared with LHRH analogues for the treatment of locally advanced prostate cancer, the phase III PATCH (NCT00303784) and STAMPEDE (NCT00268476) trials. EUROPEAN UROLOGY. 2025 MAR;87. PubMed PMID: WOS:001578719500180. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627511
Embedded videos